GH RESEARCH PLC's ticker is GHRS and the CUSIP is G3855L106. A total of 36 filers reported holding GH RESEARCH PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,964 | -15.3% | 3,081 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $36,556 | +48.5% | 3,081 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $24,617 | -17.8% | 3,081 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $29,947 | -16.8% | 3,081 | 0.0% | 0.01% | -28.6% |
| Q3 2022 | $36,000 | -12.2% | 3,081 | -24.5% | 0.01% | -12.5% |
| Q2 2022 | $41,000 | – | 4,081 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,333,154 | $38,731,000 | 5.98% |
| BVF INC/IL | 9,275,158 | $107,777,000 | 4.45% |
| ACUTA CAPITAL PARTNERS, LLC | 243,250 | $2,827,000 | 1.22% |
| RA Capital Management | 4,898,373 | $56,919,000 | 1.21% |
| RTW INVESTMENTS, LP | 2,168,957 | $25,203,000 | 0.58% |
| Cormorant Asset Management, LP | 593,043 | $6,891,000 | 0.48% |
| HighVista Strategies LLC | 56,769 | $660,000 | 0.38% |
| Orbimed Advisors | 1,622,060 | $18,848,000 | 0.35% |
| Deep Track Capital, LP | 499,400 | $5,803,000 | 0.27% |
| DAFNA Capital Management LLC | 52,631 | $612,000 | 0.16% |